Delivery Order SPE2DB22D9225-SPE2DB24FR8EB
Award Date
12/8/23
Potential Completion Date
1/2/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order....
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $4,642.20 against its indefinite delivery contract with the Defense Logistics Agency to supply 150 milligrams per milliliter syringes of Xolair. The delivery order has no set-aside designation and requires completion by December 1, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency through December 2025 to provide various pharmaceutical and medical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency Troop Support Medical to provide Xolair 150 mg/ml syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply needed pharmaceutical items and medical products to military treatment centers supported by the...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand six hundred forty-two dollars and twenty cents ($4,642.20) by the Defense Logistics Agency to supply Xolair 150 MG/ML syringes. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $77,370 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. As a woman owned small business and woman owned business, DMS Pharmaceutical Group will deliver the pharmaceutical products to Park Ridge, Illinois by December 2023. DMS Pharmaceutical Group currently supplies various medical supplies and pharmaceuticals to support military treatment facilities...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,568.80 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS Pharmaceutical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand six hundred forty-two dollars and twenty cents ($4,642.20) by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025. DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $22,437.30 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order....